Cetera Advisor Networks LLC Insulet Corp Transaction History

Cetera Advisor Networks LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$163.6 - $209.11 $241,473 - $308,646	-1,476 Reduced 54.71%	1,222 $209,000
Q4 2023 Feb 13, 2024	SELL	$127.77 - $221.42 $60,051 - $104,067	-470 Reduced 14.84%	2,698 $585,000
Q3 2023 Nov 14, 2023	SELL	$154.67 - $290.89 $43,616 - $82,030	-282 Reduced 8.17%	3,168 $505,000
Q2 2023 Aug 09, 2023	BUY	$272.48 - $330.23 $37,329 - $45,241	137 Added 4.14%	3,450 $994,000
Q1 2023 May 15, 2023	BUY	$276.36 - $326.03 $334,671 - $394,822	1,211 Added 57.61%	3,313 $1.06 Million
Q4 2022 Feb 14, 2023	BUY	$212.22 - $313.46 $446,086 - $658,892	2,102 New	2,102 $618,000
Q3 2020 Nov 13, 2020	SELL	$192.55 - $236.59 $1,347 - $1,656	-7 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$159.17 - $224.73 $1,114 - $1,573	7 New	7 $1,000

685

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.2B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.